177Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sanjeet Kumar,Jaiswal

第一单位： Department of Endocrinology, Seth G.S Medical College and KEM Hospital, Mumbai, Maharashtra, India.

作者： Sanjeet Kumar,Jaiswal ^[1] ; Vijaya,Sarathi ^[2] ; Saba Samad,Memon ^[1] ; Robin,Garg ^[1] ; Gaurav,Malhotra ^[3] ; Priyanka,Verma ^[3] ; Ravikumar,Shah ^[1] ; Manjeet Kaur,Sehemby ^[1] ; Virendra A,Patil ^[1] ; Swati,Jadhav ^[1] ; Anurag Ranjan,Lila ^[1] ; Nalini S,Shah ^[1] ; Tushar R,Bandgar ^[1]

作者单位： Department of Endocrinology, Seth G.S Medical College and KEM Hospital, Mumbai, Maharashtra, India. ^[1] Department of Endocrinology, Vydehi Institute of Medical Sciences and Research Center, Bengaluru, Karnataka, India. ^[2] Department of Nuclear Medicine, Bhabha Atomic Research Centre, Mumbai, Maharashtra, India. ^[3]

关键词 PRRT SUVmax paraganglioma pheochromocytoma predictors of response

DOI 10.1530/EC-20-0292

PMID 32784267

发布时间 2022-04-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Endocrine connections

2020年9卷9期

864-873页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

177Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma.

Endocrine connections

相似文献

Endocrine connections

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

177Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma.

Endocrine connections

相似文献

Endocrine connections

相关期刊

检索历史清除